_version_ 1784593638405177344
author Thura, Min
Al-Aidaroos, Abdul Qader
Gupta, Abhishek
Chee, Cheng Ean
Lee, Soo Chin
Hui, Kam Man
Li, Jie
Guan, Yeoh Khay
Yong, Wei Peng
So, Jimmy
Chng, Wee Joo
Ng, Chin Hin
Zhou, Jianbiao
Wang, Ling Zhi
Yuen, John Shyi Peng
Ho, Henry Sun Sien
Yi, Sim Mei
Chiong, Edmund
Choo, Su Pin
Ngeow, Joanne
Ng, Matthew Chau Hsien
Chua, Clarinda
Yeo, Eugene Shen Ann
Tan, Iain Bee Huat
Sng, Joel Xuan En
Tan, Nicholas Yan Zhi
Thiery, Jean Paul
Goh, Boon Cher
Zeng, Qi
author_facet Thura, Min
Al-Aidaroos, Abdul Qader
Gupta, Abhishek
Chee, Cheng Ean
Lee, Soo Chin
Hui, Kam Man
Li, Jie
Guan, Yeoh Khay
Yong, Wei Peng
So, Jimmy
Chng, Wee Joo
Ng, Chin Hin
Zhou, Jianbiao
Wang, Ling Zhi
Yuen, John Shyi Peng
Ho, Henry Sun Sien
Yi, Sim Mei
Chiong, Edmund
Choo, Su Pin
Ngeow, Joanne
Ng, Matthew Chau Hsien
Chua, Clarinda
Yeo, Eugene Shen Ann
Tan, Iain Bee Huat
Sng, Joel Xuan En
Tan, Nicholas Yan Zhi
Thiery, Jean Paul
Goh, Boon Cher
Zeng, Qi
author_sort Thura, Min
collection PubMed
description
format Online
Article
Text
id pubmed-8564534
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85645342021-11-19 Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein Thura, Min Al-Aidaroos, Abdul Qader Gupta, Abhishek Chee, Cheng Ean Lee, Soo Chin Hui, Kam Man Li, Jie Guan, Yeoh Khay Yong, Wei Peng So, Jimmy Chng, Wee Joo Ng, Chin Hin Zhou, Jianbiao Wang, Ling Zhi Yuen, John Shyi Peng Ho, Henry Sun Sien Yi, Sim Mei Chiong, Edmund Choo, Su Pin Ngeow, Joanne Ng, Matthew Chau Hsien Chua, Clarinda Yeo, Eugene Shen Ann Tan, Iain Bee Huat Sng, Joel Xuan En Tan, Nicholas Yan Zhi Thiery, Jean Paul Goh, Boon Cher Zeng, Qi Nat Commun Author Correction Nature Publishing Group UK 2021-11-02 /pmc/articles/PMC8564534/ /pubmed/34728638 http://dx.doi.org/10.1038/s41467-021-26548-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Thura, Min
Al-Aidaroos, Abdul Qader
Gupta, Abhishek
Chee, Cheng Ean
Lee, Soo Chin
Hui, Kam Man
Li, Jie
Guan, Yeoh Khay
Yong, Wei Peng
So, Jimmy
Chng, Wee Joo
Ng, Chin Hin
Zhou, Jianbiao
Wang, Ling Zhi
Yuen, John Shyi Peng
Ho, Henry Sun Sien
Yi, Sim Mei
Chiong, Edmund
Choo, Su Pin
Ngeow, Joanne
Ng, Matthew Chau Hsien
Chua, Clarinda
Yeo, Eugene Shen Ann
Tan, Iain Bee Huat
Sng, Joel Xuan En
Tan, Nicholas Yan Zhi
Thiery, Jean Paul
Goh, Boon Cher
Zeng, Qi
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_full Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_fullStr Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_full_unstemmed Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_short Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
title_sort author correction: prl3-zumab as an immunotherapy to inhibit tumors expressing prl3 oncoprotein
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564534/
https://www.ncbi.nlm.nih.gov/pubmed/34728638
http://dx.doi.org/10.1038/s41467-021-26548-6
work_keys_str_mv AT thuramin authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT alaidaroosabdulqader authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT guptaabhishek authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT cheechengean authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT leesoochin authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT huikamman authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT lijie authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT guanyeohkhay authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT yongweipeng authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT sojimmy authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT chngweejoo authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT ngchinhin authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT zhoujianbiao authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT wanglingzhi authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT yuenjohnshyipeng authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT hohenrysunsien authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT yisimmei authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT chiongedmund authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT choosupin authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT ngeowjoanne authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT ngmatthewchauhsien authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT chuaclarinda authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT yeoeugeneshenann authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT taniainbeehuat authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT sngjoelxuanen authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT tannicholasyanzhi authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT thieryjeanpaul authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT gohbooncher authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein
AT zengqi authorcorrectionprl3zumabasanimmunotherapytoinhibittumorsexpressingprl3oncoprotein